News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center
Logo of MD Anderson Cancer Center from X
Oct 24, 2023, 13:44

MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center

Quoting

“MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone.

“These findings showcase, for the first time, the potential of combining immunotherapy with a PARP inhibitor to deliver significant clinical improvements for these patients,” says lead investigator Shannon Westin.”

For more details click here.
cancer Endometrial cancer Headlines MD Anderson Cancer Center OncoDaily Oncology Shannon Westin
Special Coverage
Blog
Dec 2, 2024, 10:22
Tejas Patil: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in non-small cell lung cancer
Blog
Dec 2, 2024, 10:01
Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg
Blog
Dec 2, 2024, 09:57
Michael Shusterman: GI Oncology standard regimen doses remain too high for many real world patients
Positive
Dec 2, 2024, 09:46
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
Blog
Dec 2, 2024, 09:07
Support Children Battling Cancer and their Parents with The Goodwill Foundation - Onco Intelligence
Blog
Dec 2, 2024, 09:04
How can mpMRI change management of patients with NMIBC or MIBC?
Blog
Dec 2, 2024, 08:15
Nikhil Vojjala: Excited to win the Michigan state ACP Doctors dilemma championship
Insight
Dec 2, 2024, 08:12
Mattia Rediti: Our work describing HER2-positive Breast Cancer heterogeneity is out
Insight
Dec 2, 2024, 08:01
Enrique Soto: Our systematic review on the use of wearable technologies in older adults with Cancer
Insight
Dec 2, 2024, 07:43
Bishoy M. Faltas: We are looking for Postdocs Interested in studying Cancer Evolution
Blog
Dec 2, 2024, 07:40
Caitlin Delaney: I am launching my fundraiser for off-label treatments which will hopefully extend my life
Opinion
Dec 1, 2024, 22:10
Mike Thompson: Myeloma/Plasma Cell Dyscrasia Draft Table Update